Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	513.05	443.72	246.11	97.09	165.74	124.3
Depreciation & Amortization	42.34	36.03	5.32	15.94	-	-
Other Amortization	0.01	0.01	0.01	0.01	-	-
Other Operating Activities	-127.69	-101.04	11.45	-24.52	-113.92	37.95
Operating Cash Flow	427.71	378.72	262.89	88.53	51.83	162.25
Operating Cash Flow Growth	50.25%	44.06%	196.96%	70.82%	-68.06%	-
Capital Expenditures	-134.05	-139.47	-216.24	-79.07	-17.31	-23.68
Sale of Property, Plant & Equipment	-	-	-	0.08	0	0.04
Investment in Securities	-	-	-0.84	-	15.86	-14.11
Other Investing Activities	22.78	21.12	-14.5	2.85	4.94	2.62
Investing Cash Flow	-111.27	-118.35	-231.58	-76.14	3.49	-35.13
Long-Term Debt Issued	-	-	133.88	144.31	-	-
Long-Term Debt Repaid	-	-36.67	-50.76	-28.36	-	-
Net Debt Issued (Repaid)	-40	-36.67	83.12	115.95	-	-
Common Dividends Paid	-220.8	-220.78	-85.53	-100.82	-75.2	-77.73
Financing Cash Flow	-260.8	-257.45	-2.41	15.13	-75.2	-77.73
Miscellaneous Cash Flow Adjustments	0	-	-	-	-	-
Net Cash Flow	55.64	2.93	28.9	27.51	-19.89	49.39
Free Cash Flow	293.66	239.25	46.65	9.45	34.52	138.57
Free Cash Flow Growth	531.04%	412.87%	393.48%	-72.61%	-75.09%	-
Free Cash Flow Margin	12.71%	11.51%	3.43%	0.94%	3.10%	13.05%
Free Cash Flow Per Share	19.66	16.02	3.12	0.63	2.31	9.28
Cash Interest Paid	-	-	-	5.85	-	-
Cash Income Tax Paid	84.46	93	45.89	73.12	51.33	36.22
Levered Free Cash Flow	227.46	146.4	-42.26	57.94	-20.17	97.35
Unlevered Free Cash Flow	237.51	154.86	-30.42	60.12	-20.17	97.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.